ASX DXB, Dimerix (-18.18%) – DSMB CHANGE TO REMAP-CAP COVID-19 STUDY
“ REMAP-CAP independent Data Safety Monitoring Board (DSMB) conducted a scheduled interim safety assessment on available data to determine if the treatments in the RAS study domain were safe in…